Yameen et al. | Manning et al. | Bisla et al. | Singla et al. | Millan-Guerrero et al. | |
---|---|---|---|---|---|
Variables | |||||
2011 | 2019 | 2021 | 2011 | 2019 | |
Number of participants | 31 | 4 | 26 | 30 | 10 |
Sex (M,F) | 11, 20 | 1, 3 | 10,16 | 12,18 | 7,3 |
Age | 50.1 ± 11 (mean) | 56.25 (mean) | 54.3 (mean) | > 50 YOA | 64.9 (mean) |
Duration of Symptoms | > 8 weeks | 8 years (mean) | N/A | N/A | 2.1 years (mean) |
Severity of Pain (before TENS) | 8.5 ± 2.92 | 8.66 | 8.69 ± 1.123 | 8.9 ± 2.98 | 9 ± 1.333 |
Severity of Pain (after TENS) | 2 ± 1.41 | 1 ± 0 | 1.23 ± 1.632 | 1.30 ± 1.14 | 0.3 ± 0.949 |
Mode of Intervention | Constant Mode (16), Burst Mode (15) | Tonic Mode (3), Burst Mode (1) | Continuous mode (26) | N/A | N/A |
Duration of intervention (per session) | 30 min/weekly | N/A | 40 min/weekly | 20 min/daily | 60 min/NA |
Duration of Intervention (total) | 3 weeks | 1 year | 6 weeks | 1 year | N/A |
Pulse width of intervention | 120 µ | 1000 µsec | N/A | N/A | 50–200 µs |
Frequency of intervention | 200 Hz | 40 Hz | 100 Hz | N/A | 50–100 Hz |
Remission | N/A | N/A | N/A | None | 7.1 ± 2.47 at the 5-year follow-up |
Complications | N/A | Paresthesia (3), None (1) | N/A | None | N/A |
Follow-up | N/A | 3 months, 6 months,12 months | 3 months, 6 months, 12 months | 1 month, 3 months | 2 months, 3 months, 12 months, 3 years, 5 years |
Quality assessment | Moderate | Moderate | Moderate | Moderate | Serious |